Table 1 Baseline demographics and clinical characteristics of patients with exudative age-related macular degeneration
Characteristics | n=21 (%) |
|---|---|
Age at enrollment (years) Mean (median, range) | 81 (80, 69–96) |
Sex | |
Male | 5 (24) |
Female | 16 (76) |
Race | |
Caucasian | 21 (100) |
Anti-VEGF naïve | |
Yes | 2 (10) |
No | 19 (90) |
Duration of eAMD diagnosis (months) Mean (median, range) | 41 (23, 0-135) |
Most recent anti-VEGF agent | |
Bevacizumab | 18 (86) |
Aflibercept | 3 (14) |